Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Update https://tsdr.uspto.gov/#caseNumber=98115

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154804
(Total Views: 990)
Posted On: 05/31/2024 10:54:26 AM
Avatar
Posted By: Riztheinvestor
Update

https://tsdr.uspto.gov/#caseNumber=98115520&a...atusSearch

So the trademark Live Pending. It was updated Status Date: May 09, 2024
Publication Date: Jun. 11, 2024.

So this isn’t dead. Looks like we are still going to use this trademark. I took the hint to dig into our IP and there is probably more I’ll have to look into it. Doesn’t appear LIVIMMUNE was never abandoned as some suggested.

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 22, 2024


This is literally the only pending application I can find under the search. Unless someone wants to correct me but this is exactly what he was talking about.

“Finally, as to the company's IP position. This is a topic that is both a confidential legal matter as we already filed a pending application.

But it's curious too as it also involves future strategy and related confidential developments on that front. So again, we'll share what we can at this time and always excited to talk IP. First, perhaps needless to say, as a pre-revenue biotech company, our IP portfolio is our asset.“

“Again, with our IP Council, we are constantly reviewing and planning strategically around that concept. Finally, we also hope for and anticipate ongoing IP development in the coming months and updates in this regard, will be provided. Be it a public statement and / or SEC filings. So again, any updates as to new IP or related developments will only be made via public statements and or the SEC filings.”

I bet there is some sort of licensing agreements tied to this but obviously it’s not public.

https://tsdr.uspto.gov/#caseNumber=98115520&a...atusSearch


Search below

https://tmsearch.uspto.gov/search/search-results





(6)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us